Download PDF
1 / Pages

Other users also viewed these articles

Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial Roseane P. Medeiros; Norah A. Terrault; Daniel F. Mazo; Claudia P. Oliveira; Jennifer Dodge; Patricia M. Zitelli; Marta H. Lopes; Flair J. Carrilho; Mário G. Pessoa;
Ann Hepatol. 2023;28:
O-18 IMPAIRED ANTI-HBV VACCINE RESPONSE IN NON-CIRRHOTIC CHRONIC HCV PATIENTS IS NOT OVERCOME BY DOUBLE DOSE REGIMEN. FOURTH DOSE MAYBE THE ANSWER! Roseane Pôrto Medeiros; Norah A. Terrault; Daniel F. Mazo; Claudia P. Oliveira; Jennifer L. Dodge; Patricia M. Zitelli; M. Lopes; Flair J. Carrilho; Mário Guimarães Pessoa;
Ann Hepatol. 2021;24 Supl 1:
O-10 PRIMARY BILIARY CHOLANGITIS PATIENTS DIAGNOSED BY DIFFERENT COMBINATIONS OF THE DIAGNOSTIC CRITERIA PRESENT CLINICAL AND LABORATORY PECULIARITIES Guilherme G.L. Cançado; Eduardo L.R. Cançado; Maria L.G. Ferraz; Cristiane A. Villela-Nogueira; Debora R.B. Terrabuio; Michelle H. Braga; Mateus J. Nardelli; Luciana C. Faria; Nathalia M.F. GOMES; ELZE M.G. Oliveira; Vivian Rotman; Maria Beatriz Oliveira; Simone M.C.F. Cunha; Daniel F. Mazo; Liliana S.C. Mendes; Claudia A.P. Ivantes; Valéria Faborges; Fabio H.L. Pace; Mario G. Pessoa; Izabelle V. Signorelli; Gabriela P. Coral; Paulo L. Bittencourt; Cynthia Levy; Cláudia A. Couto; Members of the Brazilian Cholestasis Study Group Consortium;
Ann Hepatol. 2021;24 Supl 1: